Fred Alger Management’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
Other funds holding TRVI
Fred Alger Management's TRVI Position: Q3 2026 in Review
Fred Alger Management sold out of Trevi Therapeutics (TRVI) in Q3 2026, closing a stake of 66,490 shares — an estimated $1.24M sold.
Fred Alger Management first reported a position in TRVI in Q3 2024 and held it in 6 quarters. The position peaked at $1.98M in Q4 2025. 222 funds tracked by Wall St. Rank hold TRVI as of Q3 2026.
- Fred Alger Management reported no remaining Trevi Therapeutics position as of Q3 2026 after selling out during the quarter.
- Fred Alger Management sold 66,490 Trevi Therapeutics shares in Q3 2026, an estimated $1.24M.
- Fred Alger Management first reported a position in Trevi Therapeutics in Q3 2024 and held it in 6 quarters.
- Fred Alger Management's Trevi Therapeutics position peaked at $1.98M in Q4 2025.
- 222 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q3 2026.
Based on Fred Alger Management's 13F filing for Q3 2026, filed 16 Nov 2026.